OregaRESP
On sale on the US market (according to the DSLD)
North American Herb & Spice, food supplement from the US market
OregaRESP (North American Herb & Spice), a food supplement au code-barres 335824000951, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- North American Herb & Spice
- Barcode
- 335824000951
- Form
- Softgel
- One serving
- 1 softgel
- Servings
- number of servings per day not stated
- Other ingredients (in English, as written)
- Tapioca, Vegetable Gelatin
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Proprietary Blend | Blend | 280 mg |
| P73 | Blend | not stated |
| Cinnamon Oleoresin Extract | Plant | not stated |
| wild Sage Oil (Salvia officinalis) | Plant | not stated |
| Cumin Oil (Cuminum cyminum) | Plant | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: OregaRESP
Entered into DSLD on 16 June 2022. On sale on the US market (according to the DSLD).- Active ingredient added : Cinnamon Oleoresin (quantity not stated)
- Active ingredient added : Cumin Oil Extract, Powder (quantity not stated)
- Active ingredient added : Ginger herb powder (quantity not stated)
- Active ingredient added : Oregano (quantity not stated)
- Active ingredient added : Oregano Extract, Powder (quantity not stated)
- Active ingredient added : Sage Oil powder (quantity not stated)
- Active ingredient removed : Cinnamon Oleoresin Extract (quantity not stated)
- Active ingredient removed : Cumin Oil (quantity not stated)
- Active ingredient removed : P73 (quantity not stated)
- Active ingredient removed : wild Sage Oil (quantity not stated)
- Different quantity per serving : Proprietary Blend: 450 mg in this version; 280 mg on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- wild Sage Oil
Read the warning, when it applies and the studies cited
SAGE - SALVIA OFFICINALIS - Buccal
Cautions and warnings
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Health Canada monograph dated 28 March 2025
SAGE -SALVIA OFFICINALIS Oral
Cautions and warnings
Condition of application: Carminative, Diaphoretic, Antihidrotic, Antigalactagogue.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Condition of application: All products.
Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Bradley 2006; Mills and Bone 2005).
Sources cited by Health Canada (3)
- Bradley PR, editor. 2006: Bradley PR, editor. British Herbal Compendium Volume 2: A Handbook of Scientific Information on Widely Used Plant Drug-Companion to the British Herbal Pharmacopoeia. Bournemouth (GB): British Herbal Medicine Association; 2006.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Raton (FL): Taylor and Francis Group; 2013.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Do not use if you have a seizure disorder such as epilepsy (Gardner and McGuffin 2013; Bradley 2006; Mills and Bone 2005).
Sources cited by Health Canada (3)
- Bradley PR, editor. 2006: Bradley PR, editor. British Herbal Compendium Volume 2: A Handbook of Scientific Information on Widely Used Plant Drug-Companion to the British Herbal Pharmacopoeia. Bournemouth (GB): British Herbal Medicine Association; 2006.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Raton (FL): Taylor and Francis Group; 2013.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : North American Herb & Spice
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “OregaRESP (North American Herb & Spice): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/335824000951-oregaresp-north-american-herb-spice, updated 22 September 2022.